• No results found

University of Groningen Epstein-Barr virus-associated malignancies Tan, Geok Wee

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Epstein-Barr virus-associated malignancies Tan, Geok Wee"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Epstein-Barr virus-associated malignancies

Tan, Geok Wee

DOI:

10.33612/diss.173425402

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2021

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Tan, G. W. (2021). Epstein-Barr virus-associated malignancies: Susceptibility factors and molecular detection in liquid biopsies. University of Groningen. https://doi.org/10.33612/diss.173425402

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Propositions Belonging to the PhD thesis Epstein-Barr virus-associated malignancies Susceptibility factors and molecular detection in liquid biopsies

1. Susceptibility effects of HLA alleles are early events in pathogenesis, while the pressure on tumor cells to downregulate HLA is most likely related to emerging immune responses later on. (this thesis, chapter 3)

2. The Bidayuh, a minority population in Malaysia, have a distinct set of HLA alleles conferring risk to the development of nasopharyngeal carcinoma. (this thesis, chapter 4)

3. Biomarkers for nasopharyngeal carcinoma can be detected by non-invasive sampling in the form of nasal washings. (this thesis, chapter 6)

4. Despite the scarcity of tumor cells in Hodgkin lymphoma, copy number variations and EBV can be detected in cell-free DNA obtained at the time of diagnosis. (this thesis, chapter 7)

5. EBV-positive Hodgkin lymphomas are less dependent on activation of NF-κB pathway genes through copy number alterations. (this thesis, chapter 7)

6. Copy number variations detected in cell-free DNA of PTLD patients reflect those of biopsy tissue, indicating the presence of circulating tumor DNA. (this thesis, chapter 8)

7. Satisfaction lies in the effort, not in the attainment. (Mahatma Gandhi)

8. Success is not final; failure is not fatal. It is the courage to continue that counts. (Winston S. Churchill)

Referenties

GERELATEERDE DOCUMENTEN

In Hoofdstuk 3 en Hoofdstuk 4 werd het verlies van HLA-expressie door tumorcellen bestudeerd in de context van bekende risico- en beschermende HLA-allelen in cHL en

Door gebruik te maken van dendritische cellen voor reactivatie, en van EBV- getransformeerde B-cellen die het tumorantigeen tot overexpressie brengen voor expansie, kan een

The infused lines contained cytotoxic T-cells specific for LMP2 (an EBV antigen usually expressed by NPC tumor cells), and were biologi- cally active , reducing levels of EBV DNA

Adoptive T cell therapy as treatment for Epstein Barr Virus-associated malignancies : strategies to enhance potential and broaden application. Retrieved

Immunization with Epstein-Barr Virus (EBV) peptide-pulsed dendritic cells induces functional CD8+ T-cell immunity and may lead to tumor regression in patients with

Using a peptide library spanning the entire LMP2 sequence, 25 CTL lines from patients with EBV-positive malignancies expressing type II latency were screened for the presence

Adoptive transfer of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T-cells with in vitro antitumor activity boosts LMP2-specific immune response in a patient with

Figure 7d compares the percentage of tetramer positive CD8+ cells specific for the HLA 11*01 restricted LMP2 peptide SSC and the HLA A29*01 restricted LMP2 peptide ILL with HLA